Allspring Global Investments Holdings, LLC Pmv Pharmaceuticals, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 13, 2023	BUY	$4.77 - $9.16 $6,491 - $12,466	1,361 Added 121.41%	2,482 $11,000
Q4 2022 Jan 23, 2023	SELL	$8.17 - $12.95 $204 - $323	-25 Reduced 2.18%	1,121 $9.75 Million
Q3 2022 Oct 26, 2022	BUY	$11.4 - $17.18 $13,064 - $19,688	1,146 New	1,146 $13,000

Others Institutions Holding PMVP

# of Institutions

Shares Held

41.9M

Call Options Held

3.1K

Put Options Held

1.7K

Orbimed Advisors LLC San Diego, CA

6.48M
Shares

$10.3 Million
0.23% of portfolio
Arrow Mark Colorado Holdings LLC Denver, CO

3.65M
Shares

$5.8 Million
0.08% of portfolio
Sio Capital Management, LLC New York, NY

3.21M
Shares

$5.11 Million
2.53% of portfolio
Euclidean Capital LLC New York, NY

2.63M
Shares

$4.18 Million
0.43% of portfolio
Alkeon Capital Management LLC New York, NY

2.34M
Shares

$3.73 Million
0.01% of portfolio

View Full List

About PMV Pharmaceuticals, Inc.

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $72.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

More about PMVP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account